SPS
MRVI icon

Susquehanna Portfolio Strategies’s Maravai LifeSciences MRVI Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$647K Sell
228,733
-7,588
-3% -$25.7K 0.01% 713
2025
Q4 		$768K Buy
236,321
+208,462
+748% +$702K 0.01% 690
2025
Q3 		$80K Buy
+27,859
New +$71.1K ﹤0.01% 1011

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna Portfolio Strategies's MRVI Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Maravai LifeSciences (MRVI) stake by 3.2% in Q1 2026, selling an estimated $25.7K and leaving 228,733 shares worth $647K. The position accounts for 0.01% of the portfolio, ranked #713.

Susquehanna Portfolio Strategies first reported a position in MRVI in Q3 2025 and has held it in 3 quarters since. The position peaked at $768K in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Susquehanna Portfolio Strategies held 228,733 shares of Maravai LifeSciences worth $647K as of Q1 2026.
  • Susquehanna Portfolio Strategies sold 7,588 Maravai LifeSciences shares in Q1 2026, an estimated $25.7K.
  • Maravai LifeSciences made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #713 holding.
  • Susquehanna Portfolio Strategies first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • Susquehanna Portfolio Strategies's Maravai LifeSciences position peaked at $768K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.